Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...

Vertex Pharmaceuticals (VRTX) is rated as a "Strong Buy" due to robust revenue growth and multiple expansion opportunities ...

In this Market Dialogues episode, experts discuss what’s driving efforts to connect private market data with public workflows ...

The trading range for stock earnings multiples has shifted higher, quite possibly permanently, says Jim Paulsen ...

In the assessment of 12-month price targets, analysts unveil insights for Palantir Technologies, presenting an average target ...

The U.S. dollar has always been a critical measure of the health of the global economy, but recently this barometer has found ...